サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756482

患者血液管理市場：製品別、コンポーネント別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Patient Blood Management Market, By Product, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 365 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
患者血液管理市場：製品別、コンポーネント別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2025年05月15日
発行: AnalystView Market Insights
ページ情報: 英文 365 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

患者血液管理市場規模は2024年に154億7,898万米ドルとなり、2024～2032年にかけてCAGR 7.98%で拡大

患者血液管理市場-市場力学

貧血と慢性疾患の有病率の上昇

貧血や、心血管障害、がん、腎臓病などの慢性疾患の有病率の増加は、患者血液管理（PBM）市場成長の主要促進要因です。これらの疾患はしばしば著しい失血や赤血球産生の減少につながるため、より効果的な血液管理戦略が必要となります。世界人口の高齢化とこれらの疾患の発生率の上昇に伴い、ヘルスケアプロバイダは血液使用を最適化し、輸血の必要性を減らし、患者の転帰を改善するためにPBMに注目しています。PBM戦略は、患者に合わせた治療や介入によって貧血を管理し、輸血に伴うリスクを軽減して回復を促進します。その結果、慢性疾患による負担の増大が、血液損失を最小限に抑え、赤血球造血を改善し、従来型輸血に代わる方法を提供することに重点を置いたPBMソリューションの需要を促進しています。この動向は市場の拡大に大きく影響しています。

患者の血液管理市場-主要な洞察

当社のリサーチアナリストによると、世界の患者血液管理市場は、2024～2032年にかけて約7.98%のCAGRで発展する見込みです。

2024年の製品別セグメントでは、機器カテゴリが市場を独占しています。

エンドユーザー別では、2024年には病院が最も多くの収入を生み出しました。

地域別では、2024年に北米が最も収益を上げた地域でした。

患者血液管理市場-セグメンテーション分析

世界の患者血液管理市場は、製品、成分、エンドユーザー、地域の3つに分類されます。

患者血液管理（PBM）市場は4つの主要製品カテゴリーに区分されます：機器、付属品、試薬・キット、ソフトウェアです。このうち、市場を独占すると予想されるのは機器です。このセグメントには、採血システム、血液処理装置、血液関連状態のモニタリング・管理に使用される診断機器などの機器が含まれます。機器の優位性は、正確な血液分析を可能にし、血液損失を減らし、臨床現場における輸血の実践を強化する上で重要な役割を果たすことに起因しています。PBMは、血液損失を最小限に抑え、血液の使用を最適化することに重点を置いているため、機器はこれらの目的の中心となっています。さらに、医療技術の進歩や、血液を節約する手術手技の採用拡大が、革新的で高性能な器具の需要を押し上げています。手術やクリティカルケアにおける正確な血液管理の重要性は、ヘルスケア投資の増加と相まって、器具をPBM市場の主要製品カテゴリーとして位置づけています。

エンドユーザー別では、市場は血液バンク、病院、診断クリニック、病理ラボに区分されます。このうち、病院部門が優位を占めると考えられます。病院は、特に外科手術、外傷治療、重症患者管理など、PBMの実践が最も広く適用されている主要な医療環境です。輸血、手術、患者入院の量が多いため、病院は、血液損失を管理し、血液使用を最適化し、輸血関連のリスクを低減するための包括的なPBMシステムを必要としています。病院におけるPBMの採用が拡大している背景には、複雑な手術の増加、慢性疾患の罹患率の上昇、患者の転帰改善の重視などがあります。さらに、病院は血液管理のための先進技術を導入するようになっており、PBMの拡大に貢献しています。血液バンクや診断クリニックもPBMにおいて重要な役割を果たしているが、病院は患者の治療とケアに直接関与するため、依然として支配的なエンドユーザーです。

患者血液管理市場-地理的洞察

地域的には、患者血液管理市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらす国に基づいてさらに分割されます。

北米は患者血液管理（PBM）市場において支配的な地域であり、先進的ヘルスケアインフラと病院や医療施設におけるPBM実践の採用拡大がその原動力となっています。米国が市場をリードしており、ヘルスケアシステムはPBMソリューションを通じて輸血関連の合併症を減らし、患者の転帰を最適化することにますます注力しています。FDAのような機関からの規制上の支援と、PBMの利点に関する意識の高まりが、PBMの採用をさらに後押ししています。さらに、主要な市場参入企業の存在と血液管理機器の継続的な技術進歩が、北米市場のリーダーシップに貢献しています。この地域の旺盛なヘルスケア支出と、複雑な治療を必要とする高齢化社会が、PBMソリューションの需要をさらに押し上げています。

欧州はPBM市場のもう一つの主要地域であり、強力なヘルスケアシステム、高齢化、出血と輸血を最小限に抑えることの重視の高まりが大きな成長の要因となっています。ドイツ、英国、フランスなどの国々が欧州市場をリードしており、医療提供者は患者の安全性を高め、医療費を削減するためにPBMを採用するようになっています。欧州連合のヘルスケア施策は、特に病院や手術センターでのPBM戦略の採用を支援しています。さらに、血液を節約する手術器具や診断ツールなどの医療技術の進歩は、市場の成長を促進する上で極めて重要な役割を果たしています。ヘルスケアと患者ケアに対する欧州の先進的なアプローチは、同地域におけるPBMソリューションの継続的な需要を確実なものにしています。

患者血液管理市場-競合情勢

患者血液管理（PBM）市場の競合力学は、既存参入企業と新興イノベーターによって形成されています。Haemonetics Corporation、Fresenius SE & Co.KGaA、Terumo Corporation、Immucor, Inc.などの大手企業が市場をリードしており、安全性、効率性、規制基準への準拠を最優先した先進的なPBMソリューションを幅広く提供しています。これらの企業は、血液管理システムを改善し、輸血プロトコルを強化するための研究開発に力を入れています。新規参入企業も、先進的診断ツールや救血用手術器具などの革新的技術で市場に参入しています。こうした企業間の競争は、製品の継続的な進歩を促し、高品質のPBMソリューションの安定供給を保証しています。例えば、F. Hoffmann-La Roche Ltd.とGrifols, S.A.は製品ポートフォリオを積極的に拡大しており、B. Braun Melsungen AGとBio-Rad Laboratories, Inc.は戦略的買収や提携を通じてその地位を強化し続けています。

目次

第1章 患者血液管理市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 患者血液管理の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 患者血液管理産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 患者血液管理市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 患者血液管理市場情勢

  • 患者血液管理市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 患者血液管理市場-製品別

  • 概要
    • 製品別セグメントシェア分析
    • 機器
      • 血液処理装置
      • 遠心分離機
      • 血液細胞処理装置
      • 輸血機器
      • アフェレーシス装置
      • 血漿と血漿成分分離装置
      • 細胞回収システム
      • その他の輸血機器
      • 血液培養スクリーニング装置
      • 自動血液培養システム
      • 実験装置のサポート
      • 診断と検査機器
      • PCR機器
      • 血液分析装置
      • NGSプラットフォーム
      • 血液型判定装置
      • 血液保存装置
      • 医療用冷蔵庫
      • 医療用冷凍庫
    • 付属品
      • 注射器と針
      • バイアルとチューブ
      • 血液バッグ
      • その他の付属品
    • 試薬とキット
      • 血液培養培地
      • 血液型判定試薬
      • スライド染色試薬
      • アッセイキット
      • その他の試薬
    • ソフトウェア
      • 血液バンク管理ソフトウェア
      • 輸血管理ソフトウェア
      • その他のソフトウェア

第8章 患者血液管理市場-成分別

  • 概要
    • 成分別セグメントシェア分析
    • 全血と赤血球
    • 血漿

第9章 患者血液管理市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 血液バンク
    • 病院
    • 診断クリニックと病理学ラボ

第10章 患者血液管理市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-患者血液管理産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Haemonetics Corporation
    • Fresenius Se & Co. KGaA
    • Terumo Corporation
    • Immucor, Inc.
    • B. Braun Melsungen AG
    • Macopharma
    • Biomerieux SA
    • Kaneka Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Grifols, SA
    • F. Hoffmann-La Roche Ltd.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV5344

REPORT HIGHLIGHT

Patient Blood Management Market size was valued at USD 15,478.98 Million in 2024, expanding at a CAGR of 7.98% from 2024 to 2032.

Patient Blood Management (PBM) is a comprehensive, evidence-based approach aimed at optimizing the care of patients who may require blood transfusions. It focuses on minimizing the need for transfusions by utilizing various strategies such as improving the patient's own blood volume and quality before, during, and after medical procedures. PBM includes three main pillars: optimization of erythropoiesis (promoting the body's natural production of red blood cells), minimization of blood loss (reducing surgical and diagnostic blood loss), and patient-centered transfusion strategies (ensuring transfusions are given only when absolutely necessary). The goal of PBM is to enhance patient outcomes by improving the management of anemia, reducing the risks associated with transfusions, and promoting the use of alternatives. This approach is particularly beneficial in surgical settings, trauma care, and chronic conditions where blood management plays a vital role in recovery and overall health.

Patient Blood Management Market- Market Dynamics

Rising Prevalence of Anemia and Chronic Diseases

The increasing prevalence of anemia and chronic diseases, such as cardiovascular disorders, cancer, and kidney disease, is a major driver for the growth of the Patient Blood Management (PBM) market. These conditions often lead to significant blood loss or decreased red blood cell production, necessitating more effective blood management strategies. As the global population ages and the incidence of these diseases rises, healthcare providers are turning to PBM to optimize blood use, reduce the need for transfusions, and improve patient outcomes. PBM strategies help manage anemia through tailored therapies and interventions, reducing the risks associated with transfusions and enhancing recovery. Consequently, the growing burden of chronic diseases is driving demand for PBM solutions that focus on minimizing blood loss, improving erythropoiesis, and offering alternatives to traditional transfusions. This trend significantly impacts the market's expansion.

PATIENT BLOOD MANAGEMENT Market- Key Insights

According to our research analyst, the global Patient Blood Management Market is expected to develop at a CAGR of approximately 7.98% between 2024-2032.

Segmented by Product in 2024, the Instruments category dominated the market.

Based on End User segmentation, the Hospitals generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Patient Blood Management Market- Segmentation Analysis:

The global Patient Blood Management market is divided into three categories: product, component, end user and region.

The Patient Blood Management (PBM) market is segmented into four key product categories: Instruments, Accessories, Reagents and Kits, and Software. Among these, Instruments are expected to dominate the market. This segment includes devices such as blood collection systems, blood processing equipment, and diagnostic instruments used to monitor and manage blood-related conditions. The dominance of instruments is attributed to their critical role in enabling accurate blood analysis, reducing blood loss, and enhancing transfusion practices in clinical settings. As PBM emphasizes minimizing blood loss and optimizing blood use, instruments are central to these objectives. Additionally, advancements in medical technologies and the growing adoption of blood-saving surgical techniques drive the demand for innovative, high-performance instruments. The importance of precise blood management in surgeries and critical care, coupled with increasing healthcare investments, positions instruments as the leading product category within the PBM market.

By End User the market is segmented into Blood Banks, Hospitals and Diagnostic Clinics and & Pathology Labs. Among these, the Hospitals segment is set to dominate. Hospitals are the primary healthcare settings where PBM practices are most extensively applied, particularly in surgical procedures, trauma care, and critical patient management. With the high volume of blood transfusions, surgeries, and patient admissions, hospitals require comprehensive PBM systems to manage blood loss, optimize blood use, and reduce transfusion-related risks. The growing adoption of PBM in hospitals is driven by the increasing number of complex surgeries, the rising incidence of chronic diseases, and the emphasis on improving patient outcomes. Additionally, hospitals are increasingly implementing advanced technologies for blood management, contributing to the expansion of PBM practices. While blood banks and diagnostic clinics also play essential roles in PBM, hospitals remain the dominant end user due to their direct involvement in patient care and treatment.

Patient Blood Management Market- Geographical Insights

Geographically, the Patient Blood Management Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Patient Blood Management (PBM) market, driven by the advanced healthcare infrastructure and the growing adoption of PBM practices in hospitals and healthcare facilities. The U.S. leads the market, where healthcare systems are increasingly focusing on reducing transfusion-related complications and optimizing patient outcomes through PBM solutions. Regulatory support from agencies like the FDA, along with rising awareness about the benefits of PBM, further fuels its adoption. Additionally, the presence of key market players and continuous technological advancements in blood management instruments contribute to North America's market leadership. The region's robust healthcare spending and an aging population requiring complex medical treatments further drive the demand for PBM solutions.

Europe is another key region in the PBM market, with significant growth attributed to a strong healthcare system, an aging population, and an increasing emphasis on minimizing blood loss and transfusions. Countries such as Germany, the U.K., and France lead the European market, with healthcare providers increasingly adopting PBM practices to enhance patient safety and reduce healthcare costs. The European Union's healthcare policies support the adoption of PBM strategies, particularly in hospitals and surgical centers. In addition, advancements in medical technology, such as blood-saving surgical instruments and diagnostic tools, play a pivotal role in driving market growth. Europe's progressive approach to healthcare and patient care ensures continued demand for PBM solutions in the region.

Patient Blood Management Market- Competitive Landscape:

The competitive dynamics of the Patient Blood Management (PBM) market are shaped by both established players and emerging innovators. Major companies like Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, and Immucor, Inc. lead the market, offering a range of advanced PBM solutions that prioritize safety, efficiency, and compliance with regulatory standards. These companies focus heavily on research and development to improve blood management systems and enhance transfusion protocols. New players are also entering the market with innovative technologies, such as advanced diagnostic tools and blood-saving surgical instruments. The competition among these companies encourages continuous product advancements and ensures a steady supply of high-quality PBM solutions. For instance, F. Hoffmann-La Roche Ltd. and Grifols, S.A. have been actively expanding their product portfolios, while B. Braun Melsungen AG and Bio-Rad Laboratories, Inc. continue to strengthen their positions through strategic acquisitions and collaborations.

Recent Developments:

In 2023, Grifols acquired 25 plasma donation centers in the U.S. from BPL Plasma Inc., enhancing its capacity by approximately 1 million liters annually. This strategic move strengthens Grifols' global leadership in plasma collection, supporting the growing demand for plasma-derived therapies. The acquisition aligns with Grifols' commitment to increasing patient access to life-saving treatments.

In October 2024, Terumo Blood and Cell Technologies introduced the Reveos(TM) Automated Blood Processing System in the U.S., in collaboration with Blood Centers of America. This innovative system automates the separation of whole blood into its components platelets, plasma, and red blood cells streamlining the process and improving efficiency. Reveos aims to enhance blood center operations and meet the increasing demand for blood products.

In August 2022, Abbott Laboratories launched a new blood testing platform designed to improve the accuracy and speed of diagnostics in patient blood management. This advanced platform supports healthcare providers in making timely and informed decisions, optimizing patient outcomes, and reducing the need for unnecessary transfusions. Abbott's innovation underscores its commitment to advancing PBM practices.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT BLOOD MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Haemonetics Corporation
  • Fresenius Se & Co. KGaA
  • Terumo Corporation
  • Immucor, Inc.
  • B. Braun Melsungen AG
  • Macopharma
  • Biomerieux SA
  • Kaneka Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd.
  • Others

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Blood Processing Devices
  • Centrifuges
  • Blood Cell Processors
  • Blood Transfusion Devices
  • Apheresis Machines
  • Plasma & Plasma Component Separators
  • Cell Salvage Systems
  • Other Transfusion Devices
  • Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Laboratory Equipment
  • Diagnostic & Testing Instruments
  • PCR Instruments
  • Hematology Analyzers
  • NGS Platforms
  • Blood Grouping Analyzers
  • Blood Storage Devices
  • Medical Refrigerators
  • Medical Freezers
  • Accessories
  • Syringes & Needles
  • Vials & Tubes
  • Blood Bags
  • Other Accessories
  • Reagents and Kits
  • Blood Culture Media
  • Blood Typing Reagents
  • Slide Staining Reagents
  • Assay Kits
  • Other Reagents
  • Software
  • Blood Bank Management Software
  • Transfusion Management Software
  • Other Software

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Whole Blood & Red Blood Cells
  • Plasma

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Blood Banks
  • Hospitals
  • Diagnostic Clinics and & Pathology Labs

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Blood Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Blood Management Market Snippet by Product
    • 2.1.2. Patient Blood Management Market Snippet by Component
    • 2.1.3. Patient Blood Management Market Snippet by End User
    • 2.1.4. Patient Blood Management Market Snippet by Country
    • 2.1.5. Patient Blood Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Blood Management Key Market Trends

  • 3.1. Patient Blood Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Blood Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Blood Management Market Opportunities
  • 3.4. Patient Blood Management Market Future Trends

4. Patient Blood Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Blood Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Patient Blood Management Market Landscape

  • 6.1. Patient Blood Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Blood Management Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Instruments
      • 7.1.2.1. Blood Processing Devices
      • 7.1.2.1.1. Centrifuges
      • 7.1.2.1.2. Blood Cell Processors
      • 7.1.2.2. Blood Transfusion Devices
      • 7.1.2.2.1. Apheresis Machines
      • 7.1.2.2.2. Plasma & Plasma Component Separators
      • 7.1.2.2.3. Cell Salvage Systems
      • 7.1.2.2.4. Other Transfusion Devices
      • 7.1.2.3. Blood Culture Screening Devices
      • 7.1.2.3.1. Automated Blood Culture Systems
      • 7.1.2.3.2. Supporting Laboratory Equipment
      • 7.1.2.4. Diagnostic & Testing Instruments
      • 7.1.2.4.1. PCR Instruments
      • 7.1.2.4.2. Hematology Analyzers
      • 7.1.2.4.3. NGS Platforms
      • 7.1.2.4.4. Blood Grouping Analyzers
      • 7.1.2.5. Blood Storage Devices
      • 7.1.2.5.1. Medical Refrigerators
      • 7.1.2.5.2. Medical Freezers
    • 7.1.3. Accessories
      • 7.1.3.1. Syringes & Needles
      • 7.1.3.2. Vials & Tubes
      • 7.1.3.3. Blood Bags
      • 7.1.3.4. Other Accessories
    • 7.1.4. Reagents and Kits
      • 7.1.4.1. Blood Culture Media
      • 7.1.4.2. Blood Typing Reagents
      • 7.1.4.3. Slide Staining Reagents
      • 7.1.4.4. Assay Kits
      • 7.1.4.5. Other Reagents
    • 7.1.5. Software
      • 7.1.5.1. Blood Bank Management Software
      • 7.1.5.2. Transfusion Management Software
      • 7.1.5.3. Other Software

8. Patient Blood Management Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Whole Blood & Red Blood Cells
    • 8.1.3. Plasma

9. Patient Blood Management Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Blood Banks
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Clinics and & Pathology Labs

10. Patient Blood Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Patient Blood Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Patient Blood Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Patient Blood Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Patient Blood Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Patient Blood Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Patient Blood Management Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Haemonetics Corporation
    • 11.2.2. Fresenius Se & Co. KGaA
    • 11.2.3. Terumo Corporation
    • 11.2.4. Immucor, Inc.
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. Macopharma
    • 11.2.7. Biomerieux SA
    • 11.2.8. Kaneka Corporation
    • 11.2.9. Bio-Rad Laboratories, Inc.
    • 11.2.10. Abbott Laboratories
    • 11.2.11. Grifols, S.A.
    • 11.2.12. F. Hoffmann-La Roche Ltd.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us